#GUOncology
LightNews LightNews
onclive.bsky.social
Belzutifan-Based Combinations Meet DFS, PFS End Points in Renal Cell Carcinoma #oncology #RCC #GUoncology
www.onclive.com/view/belzuti...
Belzutifan-Based Combinations Meet DFS, PFS End Points in Renal Cell Carcinoma | OncLive
Two belzutifan-based combinations met their respective primary efficacy end points of DFS and PFS in the phase 3 LITESPARK-022 and LITESPARK-011 trials.
www.onclive.com
October 28, 2025 at 3:18 PM
oncoassist.bsky.social
🎥 New on #OncologyBytes

Dr Banna & Dr Kanesvaran reflect on a record-breaking urology cancer summit:

🧠 Mini-orals, 1100+ global participants, new IUCS Association

📺 Watch: youtu.be/Z-Q4xr0F6tY

#ONCOassist #PrecisionOncology #CancerCare #GUoncology #ONCOassist #CancerCare #IUCS2025 #Oncoalert
]
Dr Banna & Dr Kanesvaran reflect on Innovation, Diversity & Global Impact at IUCS 2025 #oncology
🎥 Oncology Bytes – IUCS 2025 | Featuring Dr. Giuseppe Banna & Dr. Ravindran Kanesvaran In this special recap from IUCS 2025, Dr. Giuseppe Banna and Dr. Ravindran Kanesvaran reflect on the…
youtu.be
October 28, 2025 at 1:23 PM
oncoassist.bsky.social
🎥 New on #OncologyBytes

Dr. Petros Grivas at #IUCS2025 discusses global equity, biomarkers, & patient-centeed care in GU cancers.

“Collaboration is key to moving the field forward.”

📺 Watch: youtu.be/hB-__9aagnU

#ONCOassist #PrecisionOncology #CancerCare #GUoncology #ONCOassist #CancerCare
Oncology Bytes: Dr Petros Grivas on Global Collaboration & Genitourinary Oncology | IUCS 2025
🎥 Oncology Bytes – IUCS 2025 | Featuring Dr. Petros Grivas Dr. Petros Grivas (Clinical Director, GU Cancers Program, University of Washington) offers a deep dive into the evolving landscape of…
youtu.be
October 21, 2025 at 1:48 PM
medthority.bsky.social
What were the key takeaways from today’s proffered paper session on GU tumors, prostate, penile, and testicular cancers at #ESMO25? Read our thread below to get the updates you need to know from @dmukherji.bsky.social, Derya Tilki and colleagues #OncSky #MedSky #ProstateCancer #GUOncology
October 19, 2025 at 10:09 AM
onclive.bsky.social
Belzutifan Plus Pembrolizumab and Lenvatinib Improves Efficacy in Advanced Clear Cell #RCC #ESMO25 #KidneyCancer #GUoncology

www.onclive.com/view/belzuti...
Belzutifan Plus Pembrolizumab and Lenvatinib Improves Efficacy in Advanced Clear Cell RCC | OncLive
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
www.onclive.com
October 18, 2025 at 1:09 PM
onclive.bsky.social
Combining Durvalumab With BCG Yields Significant DFS Benefit vs BCG Alone in BCG-Naive #NMIBC #ESMO25 #oncology #GUoncology

www.onclive.com/view/combini...
Combining Durvalumab With BCG Yields Significant DFS Benefit vs BCG Alone in BCG-Naive NMIBC | OncLive
Durvalumab plus BCG induction and maintenance therapy yielded clinically meaningful improvement in DFS vs BCG induction and maintenance therapy alone in BCG-naive, high-risk NMIBC.
www.onclive.com
October 17, 2025 at 7:02 PM
scri.com
🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #WorldGU2025 on Oncology Decoded.
🔗 www.cancernetwork.com/view/episode...
#SCRI #CancerResearch #GUOncology #OncologyDecoded
Episode 12: Variant Histology Treatment Considerations From World GU 2025 | CancerNetwork
Experts highlight methods for optimally treating patients with genitourinary cancers harboring variant histologies at World GU 2025.
www.cancernetwork.com
September 26, 2025 at 6:58 PM
msklibrary.bsky.social
#ProstateCancerResearch #ProstateCancerTreatment
#GUOncology #RadiationOncology #RadOnc #MRIGuidedRadiation #CancerCare #CancerResearch #OncologyInnovation #QualityOfLife
mskcancercenter.bsky.social Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · Sep 24
Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️
The Latest Radiation Therapy for Prostate Cancer: What Every Man Should Know
It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.
www.mskcc.org
September 25, 2025 at 2:19 PM
myesmo.bsky.social
👉 Registration for #EMUC25 is OPEN!
Join the leading GU cancers congress in Prague, 13–16 Nov 2025.
🔹 Multidisciplinary programme
🔹 Networking with global experts
🔹 Discounted fees until 30 Oct

🔗 Register now: buff.ly/CJbS5HR

#GUoncology #MedicalCongress #OncologyResearch
September 8, 2025 at 1:27 PM
myesmo.bsky.social
📣 EMUC25 – Register now!
⏰ Discounted fees until 30 October. Don’t miss a leading GU cancers congress.

🔗 buff.ly/BlhJMRF

#EMUC25 #GUoncology #MedicalCongress #OncologyResearch #EAU #ESTRO
August 25, 2025 at 6:02 PM
siu-urology.bsky.social
📅 Add the B2B to your Congress schedule: Friday, October 31
🎯 Don’t miss out on early registration rates!
📌 Register BEFORE June 30 and SAVE up to 200 €! bit.ly/3E2ir3Z

We look forward to welcoming you for an all-day programme dedicated to key advances in #GUOncology.
Registration | Société Internationale d'Urologie
bit.ly
June 11, 2025 at 7:35 PM
oncoalert.bsky.social
The #ASCO25 #OncoAlertTOP10 Abstracts in #GUOncology These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸
#ProstateCancer #BladderCancer #kidneyCancer
May 30, 2025 at 7:57 PM
profiand.bsky.social
Amazing work by Ed Kwan and team, well done!
@anzuptrials.bsky.social @monashuniversity.bsky.social @easternhealthau.bsky.social @drmhofman.bsky.social @pcf-science.bsky.social #MonashBDI #EHCSMonash #AlexWyatt #ArunAzad #VanProstateCtr #PCFA #ASCO25 #TheraP #ProstateCancer #pcsm #GUOncology
Thread by @EdmondMKwan on Thread Reader App
@EdmondMKwan: On the eve of #ASCO25, I am delighted to share results from the correlative analyses of the @ANZUPtrials phase II TheraP study, now published in @NatureMedicine. Massive effort supported...
threadreaderapp.com
May 27, 2025 at 11:08 PM
siu-urology.bsky.social
Missed the 6th #B2BGUCancersTriad at #SIU2024NewDelhi? Read the meeting proceedings in the latest issue of #SIUJ and on #SIUAcademy for a full recap of the main advances in #GUoncology from 2024.
Access now: bit.ly/4gXX1CD

#OpenAccess #Journal #Urology #Urooncology #UroSoMe
March 12, 2025 at 8:21 PM
siu-urology.bsky.social
The Proceedings from the 6th #B2BGUCancersTriad Meeting are available in the latest #SIUJ issue and the #SIUAcademy. Discover recent advances in #GUoncology presented at #SIU2024NewDelhi.

📖 Access the full proceedings here: bit.ly/4gXX1CD

#OpenAccess #Journal #Urology #Urooncology
March 4, 2025 at 4:06 PM
siu-urology.bsky.social
Review the main advances in #GUoncology from 2024. Explore the proceedings from the 6th #B2BGUCancersTriad Meeting, available now in the latest #SIUJ issue and the #SIUAcademy: bit.ly/4gXX1CD
#OpenAccess #SIU2024NewDelhi
February 27, 2025 at 8:38 PM
siu-urology.bsky.social
Missed the 6th #B2BGUCancersTriad at #SIU2024NewDelhi? Read the meeting proceedings in the latest issue of #SIUJ and on #SIUAcademy for a full recap of the main advances in #GUoncology from 2024.
Access now: bit.ly/4gXX1CD
#OpenAccess #Journal #Urology #Urooncology #UroSoMe
February 26, 2025 at 7:04 PM
oncodaily.bsky.social
TROPiCS04 P3 trial data has been published - Petros Grivas

oncodaily.com/insight/petr...

#Cancer #CancerResearch #UrothelialCarcinoma #ClinicalTrial #GUOncology #Medicine #Health #Oncology #OncoDaily
Petros Grivas: TROPiCS04 P3 trial data has been published - OncoDaily
Petros Grivas: TROPiCS04 P3 trial data has been published / A. Necchi, C. Vulsteke, C.N. Sternberg, C.S. Sima, cancer, F. Boateng, I. Durán, J. Bellmunt, J.
oncodaily.com
February 14, 2025 at 9:45 PM
drchoueiri.bsky.social
Closing day of attending  @brighamandwomens.bsky.social @Dana- with this year’s amazing BWH/BIDMC housestaff!  Breadth of cases to learn from in and outside #GUoncology and comfort zone! Now, taking a moment with Wally (Red Sox) at end of rotation!
January 19, 2025 at 6:57 PM
yukselurun.bsky.social
FDA Approvals for GU Cancers in 2024: Advancing Treatment Options!
#GUOncology #Cancer #FDA #Oncology @oncoalert.bsky.social @uroweb.bsky.social @oncbrothers.bsky.social
@drchoueiri.bsky.social @viveksubbiah.bsky.social
@erplimackmd.bsky.social
@charlesryanmd.bsky.social @gu-cast.bsky.social
December 30, 2024 at 5:36 PM
profiand.bsky.social
#Genitourinary #Oncology #GUonc #GUoncol #GUoncology #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Oncsky #Medtwitter

go.bsky.app/DtoXvaD
December 28, 2024 at 9:45 PM
oncodaily.bsky.social
GU oncologist Position at Fred Hutchinson Cancer Center - Petros Grivas

oncodaily.com/career/214637

#Cancer #FredHutchinsonCancerCenter #GUOncology #OncoDaily #Oncology #Medicine #Health
Petros Grivas: GU oncologist Position at Fred Hutchinson Cancer Center - OncoDaily
Petros Grivas: GU oncologist Position at Fred Hutchinson Cancer Center / cancer, Fred Hutchinson Cancer Center, GU Oncology, OncoDaily, Oncology, Petros Grivas
oncodaily.com
December 28, 2024 at 4:57 PM
drkomanduri.bsky.social
Sadly sharing in the grief after the death of Felix Feng, MD, an extraordinary @ucsfhealth.bsky.social physician-scientist and beloved colleague/mentor to many in the Hematology/Oncology Division at @ucsfcancer.bsky.social. A profound loss for us and for cancer research. #RadOnc #GUOncology #Cancer
December 11, 2024 at 11:44 PM
markuseckstein3.bsky.social
Great review! NECTIN4 is an exciting target. More to come !
#cancer #jcoprecisionmedicine #bladdercancer #guoncology #biomarker
December 11, 2024 at 9:10 AM
profiand.bsky.social
85 people in here now, and growing - come and join us!

#Genitourinary #Oncology #GUonc #GUoncol #GUoncology #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Oncsky #Medtwitter

go.bsky.app/DtoXvaD
December 7, 2024 at 9:29 PM